Unlocking the potential of Ultrasound

There are nearly 50 million medical practitioners in the world,  most of whom do not have the skills required to scan with ultrasound.

Our intelligent ultrasound software and simulation platforms aim to train, guide, support and ultimately enable automated ultrasound scanning for every medical practitioner.

Silicon Review
Education Technology Insights
 

clinical training
through simulation

Based in Cardiff (UK) and Atlanta (USA), the intelligent ultrasound simulation division focuses on hi-fidelity ultrasound education and training through simulation.

Its three main products are the ScanTrainer, HeartWorks and BodyWorks.

Learn more
 

INTELLIGENT ULTRASOUND

 

Clinical guidance
& image analysis

Based in Oxford (UK), the intelligent ultrasound clinical support division develops augmented reality and deep-learning based algorithms to improve clinical guidance and image analysis in ultrasound.

Products in development include ScanNav and NeedleGuide.

Learn more

AIM Rule 26

The following information is being disclosed for the purposes of Rule 26 of the AIM Rules for Companies. Last updated 26 September 2018.
_____________________

Directors and Committees

Please click here for the names, responsibilities and brief biographies of our Directors including details of committees and their members.
_____________________

Country of incorporation and main country of operation

Country of Incorporation: England and Wales
Registered office: The Medicentre, Heath Park, Cardiff, Wales CF14 4UJ
Company Registration Number: 09028611
Main Country of Operation: United Kingdom

_____________________

About MedaPhor Group Plc

MedaPhor Group Plc is headquartered in Cardiff, UK and has offices in Oxford, UK and Alpharetta, GA, USA. The Group’s customers are some of the world’s leading medical institutions. Our guiding principle is to develop world-class ultrasound software and simulation technologies that will improve the quality and speed of ultrasound scanning in the clinical environment.

MedaPhor Group plc was admitted to the Alternative Investment Market (AIM) of the London Stock Exchange on 27 August 2014.

MedaPhor Group plc is subject to the UK City Code on Takeovers and Mergers.

_____________________

Details of any other exchanges or trading platforms

The Company is not listed on any other exchanges or trading platforms.

_____________________

Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.

_____________________

Number of securities in issue

Please click here for the number of securities in issue, the number of securities held as treasury shares and, insofar as the Company is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.

_____________________

Company reports

Please click here for our last annual report and all subsequent reports.

_____________________

Notifications

Please click here for details of all notifications made in the past twelve months.

_____________________

Advisors

Please click here for details of the Company’s Nominated Advisor and other key advisors.

_____________________

Corporate Governance

Please click here for a link to a statement on the Company’s application of the principles of the QCA Corporate Governance Code.

Articles of Association
Download our Articles of Association

Admission Document

Document in respect of the company’s admission to AIM on 27th August 2014
Download our Admission